Floria, M.; Oancea, A.F.; Morariu, P.C.; Burlacu, A.; Iov, D.E.; Chiriac, C.P.; Baroi, G.L.; Stafie, C.S.; Cuciureanu, M.; Scripcariu, V.;
et al. An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation. Pharmaceutics 2024, 16, 517.
https://doi.org/10.3390/pharmaceutics16040517
AMA Style
Floria M, Oancea AF, Morariu PC, Burlacu A, Iov DE, Chiriac CP, Baroi GL, Stafie CS, Cuciureanu M, Scripcariu V,
et al. An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation. Pharmaceutics. 2024; 16(4):517.
https://doi.org/10.3390/pharmaceutics16040517
Chicago/Turabian Style
Floria, Mariana, Alexandru Florinel Oancea, Paula Cristina Morariu, Alexandru Burlacu, Diana Elena Iov, Cristina Petronela Chiriac, Genoveva Livia Baroi, Celina Silvia Stafie, Magdalena Cuciureanu, Viorel Scripcariu,
and et al. 2024. "An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation" Pharmaceutics 16, no. 4: 517.
https://doi.org/10.3390/pharmaceutics16040517
APA Style
Floria, M., Oancea, A. F., Morariu, P. C., Burlacu, A., Iov, D. E., Chiriac, C. P., Baroi, G. L., Stafie, C. S., Cuciureanu, M., Scripcariu, V., & Tanase, D. M.
(2024). An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation. Pharmaceutics, 16(4), 517.
https://doi.org/10.3390/pharmaceutics16040517
